Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Roswell Park Cancer Institute
Kiadis Pharma
M.D. Anderson Cancer Center
Gamida Cell -Teva Joint Venture Ltd.
National Cancer Institute (NCI)
Virginia Commonwealth University
Royal Marsden NHS Foundation Trust